FindTrial
Sign In

A STUDY TO COMPARE THE EFFICACY OF VIDANGADI LAUHA AND TRYUSHANADYA LAUHA IN THE MANAGEMENT OF MANDHUMEHA (DIABETES MELLITUS,TYPE-II)

A COMPARATIVE STUDY OF VIDANGADI LAUHA AND TRYUSHANADYA LAUHA IN THE MANAGEMENT OF MANDHUMEHA (DIABETES MELLITUS,TYPE-II)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/04/006812
Enrollment
34
Registered
2016-04-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- MADHUMEHA (DIABETES MELLITUS TYPE-II0

Interventions

Intervention1: GROUP-B TRYUSHANADYA LAUHA: 1gram(4tablet)daily in 2 devided doses for 8 weeks Control Intervention1: GROUP-A VIDANGADI LAUHA: 1gram(4tablet) daily in 2 devided doses for 8 weeks

Sponsors

GOVT AKHANDANAND AYURVEDA COLLEGE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: PATIENTS BETWEEN AGE GROUP OF 20 YEARS TO 60 YEARS WITH SYMPTOMS OF MADHUMEHA (DIABETES MELLITUS TYPE-II) PATIENTS HAVING FASTING BLOOD SUGAR IN THE RANGE OF >126 TO 140 TO <350 mg/dl WILL BE TAKEN FOR STUDY

Exclusion criteria

Exclusion criteria: PATIENTS WITH GESTATIONAL DIABETES MELLITUS, DIABETIC NEUROPATHY,HEART DISEASES ETC.

Design outcomes

Primary

MeasureTime frame
CLINICAL IMPROVEMENT IN SIGNS AND SYMPTOMS OF DISEASE WILL BE ASSESS BY PREPARING CLINICAL PROFORMATimepoint: 8 WEEKS—

Secondary

MeasureTime frame
COMPARATIVE EFFECTIVENESS OF VIDANGADI LAUHA AND TRYUSHANADYA LAUHA WILL BE STUDIEDTimepoint: NIL—

Countries

India

Contacts

Public ContactMR PRADEEPKUMAR GAYAPRASAD SINGH

GOVT AKHANDANAND AYURVEDA COLLEGE, AHMEDABAD

ashokpandya01@yahoo.com9879090959

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026